Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,546.80
(
0.11%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
96.08
(
-0.44%
)
Bitcoin
70,738.00
(
0.31%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 240839

Monday, 12/13/2021 8:14:07 PM

Monday, December 13, 2021 8:14:07 PM

Post# of 257275
Thanks for weighing in.

Transplanters believe in SCT not because they are afraid to lose business (they can easily switch over to doing CARTs, their institutions are equipped to handle CRS), but because the jury is still out on whether CART is curative.

Even if transplanters are equipped to do CAR-T, can they make as much money per patient from CAR-T as they currently do from SCT?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today